Investment Thesis
REX demonstrates fortress-like financial health with minimal debt, exceptional liquidity, and robust free cash flow generation, but faces headwinds from weak revenue growth (+1.2% YoY) and declining net income (-12.8% YoY) that signal operational challenges in a cyclical chemical industry. The company's strong balance sheet provides downside protection, but lack of momentum and profit margin pressure limit upside appeal.
Strengths
- Fortress balance sheet with 0.02x debt-to-equity and $188.7M cash position providing strategic flexibility
- Exceptional liquidity metrics (5.94x current ratio, 5.56x quick ratio) and 29.5x interest coverage ratio indicate zero financial distress risk
- Positive free cash flow generation of $49.4M with 7.6% FCF margin supports capital allocation flexibility and potential shareholder returns
Risks
- Net income declined 12.8% YoY despite revenue growth, indicating operational margin compression and cost control challenges
- Anemic revenue growth of only 1.2% YoY suggests limited organic growth in a commodity-exposed chemical sector
- Industrial organic chemicals sector is cyclical; current slowdown in profitability may reflect broader industry headwinds rather than company-specific strengths
Key Metrics to Watch
- Operating margin trend (currently 9.4% but declining)
- Revenue growth acceleration or stabilization in next quarters
- Free cash flow sustainability and cash conversion efficiency
Financial Metrics
Revenue
650.5M
Net Income
83.0M
EPS (Diluted)
$2.50
Free Cash Flow
49.4M
Total Assets
797.7M
Cash
188.7M
Profitability Ratios
Gross Margin
14.4%
Operating Margin
9.4%
Net Margin
12.8%
ROE
13.6%
ROA
10.4%
FCF Margin
7.6%
Balance Sheet & Liquidity
Current Ratio
5.94x
Quick Ratio
5.56x
Debt/Equity
0.02x
Debt/Assets
0.2%
Interest Coverage
29.50x
Long-term Debt
14.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-09T00:10:21.218925 |
Data as of: 2026-01-31 |
Powered by Claude AI